大东方：转让控股孙公司金华联济医院有限公司股权及债权

Core Viewpoint - The company, Da Dongfang, announced the transfer of an 80% stake in Jinhua Lianji Hospital and related debts to a biotechnology firm, indicating a strategic shift in its healthcare investments [1] Group 1: Company Actions - Da Dongfang's subsidiary, Shanghai Junyao Medical Health Technology Co., plans to transfer 80% of its stake in Jinhua Lianji Hospital to Jinhua Lin Tian Biotechnology Co. for 1 yuan [1] - The debts owed to Junyao Medical by Jinhua Lianji, totaling approximately 89.99 million yuan, will be transferred for 580,000 yuan [1] Group 2: Financial Overview - For the first half of 2025, Da Dongfang's revenue composition is as follows: medical services at 79.25%, department store retail at 14.91%, food and beverage sales at 5.7%, and other at 0.57%, with a negative offset of -0.44% [1] - As of the report, Da Dongfang's market capitalization stands at 4.4 billion yuan [1]